Difference between revisions of "Template:Team:Utrecht/MainBody"

Line 130: Line 130:
 
     margin-bottom: 30px;
 
     margin-bottom: 30px;
 
}
 
}
 +
 +
.slick-slide { opacity: 0.6; }
 +
.slick-current { opacity: 1; z-index: 10; }
  
 
.slick-dots
 
.slick-dots
Line 238: Line 241:
 
     -webkit-tap-highlight-color: transparent;
 
     -webkit-tap-highlight-color: transparent;
 
}
 
}
 +
 +
.slick-slider .slick-slide { transition: opacity 0.5s !important; }
  
 
.slick-list
 
.slick-list
Line 2,826: Line 2,831:
 
<div style="clear: both;"></div>
 
<div style="clear: both;"></div>
  
<div class="sponsors_slider" style="width: 100%;">
+
<div style="position: relative; width: 100%;">
<div style="width: 150px;"><img src="https://static.igem.org/mediawiki/2017/e/e0/Uu17logo.png"></div>
+
<div class="sponsors_slider" style="width: 100%;">
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/e/e6/Uurivm.png"></div>
+
<div style="width: 150px;"><img src="https://static.igem.org/mediawiki/2017/e/e0/Uu17logo.png"></div>
<div style="width: 250px;"><img src="https://static.igem.org/mediawiki/2017/5/5b/Uudsm.jpeg"></div>
+
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/e/e6/Uurivm.png"></div>
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/9/92/Uutakara.jpg"></div>
+
<div style="width: 250px;"><img src="https://static.igem.org/mediawiki/2017/5/5b/Uudsm.jpeg"></div>
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/3/38/Uusnapgene.png"></div>
+
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/9/92/Uutakara.jpg"></div>
<div style="width: 275px;"><img src="https://static.igem.org/mediawiki/2017/e/e3/Uuelabjournal.png"></div>
+
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/3/38/Uusnapgene.png"></div>
<div style="width: 250px;"><img src="https://static.igem.org/mediawiki/2017/5/5c/Uuidt.jpg"></div>
+
<div style="width: 275px;"><img src="https://static.igem.org/mediawiki/2017/e/e3/Uuelabjournal.png"></div>
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/4/43/Uumathworks.png"></div>
+
<div style="width: 250px;"><img src="https://static.igem.org/mediawiki/2017/5/5c/Uuidt.jpg"></div>
<div style="width: 200px;"><img src="https://static.igem.org/mediawiki/2017/6/67/Speechrepublic.png"></div>
+
<div style="width: 300px;"><img src="https://static.igem.org/mediawiki/2017/4/43/Uumathworks.png"></div>
<div style="width: 275px;"><img src="https://static.igem.org/mediawiki/2017/d/db/Uubiolabs.png"></div>
+
<div style="width: 200px;"><img src="https://static.igem.org/mediawiki/2017/6/67/Speechrepublic.png"></div>
<div style="width: 200px;"><img src="https://static.igem.org/mediawiki/2017/0/05/Ufonds.png"></div>
+
<div style="width: 275px;"><img src="https://static.igem.org/mediawiki/2017/d/db/Uubiolabs.png"></div>
 +
<div style="width: 200px;"><img src="https://static.igem.org/mediawiki/2017/0/05/Ufonds.png"></div>
 +
</div>
 +
<div style="pointer-events: none; position: absolute; top: 0; left: 0; width: 30%; height: 100%;
 +
background: -moz-linear-gradient(left, rgba(255,255,255,1) 0%, rgba(255,255,255,0) 100%); /* FF3.6-15 */
 +
background: -webkit-linear-gradient(left, rgba(255,255,255,1) 0%,rgba(255,255,255,0) 100%); /* Chrome10-25,Safari5.1-6 */
 +
background: linear-gradient(to right, rgba(255,255,255,1) 0%,rgba(255,255,255,0) 100%); /* W3C, IE10+, FF16+, Chrome26+, Opera12+, Safari7+ */
 +
filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ffffff', endColorstr='#00ffffff',GradientType=1 ); /* IE6-9 */
 +
"></div>
 +
<div style="pointer-events: none; position: absolute; top: 0; right: 0; width: 30%; height: 100%;
 +
background: -moz-linear-gradient(left, rgba(255,255,255,0) 0%, rgba(255,255,255,1) 100%); /* FF3.6-15 */
 +
background: -webkit-linear-gradient(left, rgba(255,255,255,0) 0%,rgba(255,255,255,1) 100%); /* Chrome10-25,Safari5.1-6 */
 +
background: linear-gradient(to right, rgba(255,255,255,0) 0%,rgba(255,255,255,1) 100%); /* W3C, IE10+, FF16+, Chrome26+, Opera12+, Safari7+ */
 +
filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff', endColorstr='#ffffff',GradientType=1 ); /* IE6-9 */
 +
"></div>
 +
 
</div>
 
</div>
  
Line 2,875: Line 2,895:
 
Our team collaborated with the Wageningen team to obtain independent validations of both our and their biobricks.
 
Our team collaborated with the Wageningen team to obtain independent validations of both our and their biobricks.
 
<br><br>
 
<br><br>
Wageningen validated the secreted-Cas9 and secreted-Cpf1 biobricks for us (BB_numbers). Members of the Wageningen team came to Utrecht to perform this validation together with members of the Utrecht team in our lab. Hek293T-cells were transfected with secreted-Cas9 or secreted-Cpf1 or with regular intracellular Cas9 or Cpf1 as a control. Medium of the cells was analysed on a western blot to compare extracellular protein expression. This tells us whether Cas9 and Cpf1 are truly being secreted or if they just leak out of the cells. The results of this validation can be found on the Parts Page (> Links to [Basic Parts]) and the experimental page on secreted Cas9 and Cpf1. (>Links to [Experimental][Secreted])
+
Wageningen validated the secreted-Cas9 and secreted-Cpf1 biobricks for us (BB_numbers).  
 +
Members of the Wageningen team came to Utrecht to perform this validation together with members of the Utrecht team in our lab.  
 +
Hek293T-cells were transfected with secreted-Cas9 or secreted-Cpf1 or with regular intracellular Cas9 or Cpf1 as a control.  
 +
Medium of the cells was analysed on a western blot to compare extracellular protein expression.  
 +
This tells us whether Cas9 and Cpf1 are truly being secreted or if they just leak out of the cells.  
 +
The results of this validation can be found on the <a onclick="return change_page('basicparts', 1)" href="basicparts">Parts Page</a> and the experimental page on <a onclick="return change_page('secretion', 1)" href="secretion">secreted Cas9 and Cpf1</a>.
 
<br><br>
 
<br><br>
In return, for the Wageningen team, we did a blind validation of some of their biobricks. We performed a CpxR BiFC measurement, where E.coli K12 cells were transformed with the pSB1C3-araCpBAD-CpxReYFPn-CpxReYFPc plasmid. Fluorescence was then measured over the course of 6 hours.(>Links to [Wageningen Collab Page]) We also performed a leucine zipper BiFC measurement, where we transformed split sfGFP and split Venus to E.coli K12 and also full sfGFP and full Venus as controls. Cells were then lysed and fluorescence was measured in the cell lysate. (>Links to [Wageningen Collab Page])  
+
In return, for the Wageningen team, we did a blind validation of some of their biobricks.  
 +
We performed a CpxR BiFC measurement, where E.coli K12 cells were transformed with the pSB1C3-araCpBAD-CpxReYFPn-CpxReYFPc plasmid.  
 +
Fluorescence was then measured over the course of 6 hours <a target=_BLANK href="https://2017.igem.org/Team:Wageningen_UR/Collaborations" class="url_external">(link)</a>.
 +
We also performed a leucine zipper BiFC measurement, where we transformed split sfGFP and split Venus to E.coli K12 and also full sfGFP and full Venus as controls.  
 +
Cells were then lysed and fluorescence was measured in the cell lysate <a target=_BLANK href="https://2017.igem.org/Team:Wageningen_UR/Collaborations" class="url_external">(link)</a>.
  
 
<br><br>
 
<br><br>
Line 2,885: Line 2,914:
 
<h2 class="subhead" id="subhead-3">RIVM (National Institute for Public Health and the Environment)</h2>
 
<h2 class="subhead" id="subhead-3">RIVM (National Institute for Public Health and the Environment)</h2>
  
As safety is a very important aspect in synthetic biology, we collaborated with the RIVM National Institute for Public Health and Environment of the Netherlands. They encouraged us to think about safety for different stakeholders. The information we gathered was summarized in an infographic, which we used to talk to the general public about synthetic biology and safety at an event organized by the RIVM. (>Links to [Human Practices][Safety])
+
As safety is a very important aspect in synthetic biology, we collaborated with the RIVM National Institute for Public Health and Environment of the Netherlands. They encouraged us to think about safety for different stakeholders.  
 +
The information we gathered was summarized in an infographic, which we used to talk to the general public about synthetic biology and safety at an event organized by the RIVM (see <a onclick="return change_page('safety', 1)" href="safety">Safety</a>).
  
 
<br><br>
 
<br><br>
Line 2,892: Line 2,922:
 
<br><br>
 
<br><br>
 
<h2 class="subhead" id="subhead-4">Dutch national science platform "De Kennis van Nu"</h2>
 
<h2 class="subhead" id="subhead-4">Dutch national science platform "De Kennis van Nu"</h2>
Besides working in the lab on creating a diagnostic tool, we also tried to reach out to the public to make our project (and science in general) accessible and understandable to everyone. To achieve this, we collaborated with ‘de Kennis van Nu’, a Dutch platform of the national public broadcasting organization, that brings different scientific themes to the general public in an understandable way. On this platform we explain the formation of Utrecht’s first team, our design and how we are trying to solve healthcare problems. More information and some of the short videos we made can be found on our Outreach page (>Links to [Human Practices][Outreach]) and on the website of “De Kennis van Nu”
+
Besides working in the lab on creating a diagnostic tool, we also tried to reach out to the public to make our project (and science in general) accessible and understandable to everyone. To achieve this, we collaborated with ‘de Kennis van Nu’, a Dutch platform of the national public broadcasting organization, that brings different scientific themes to the general public in an understandable way. On this platform we explain the formation of Utrecht’s first team, our design and how we are trying to solve healthcare problems.  
(>https://www.dekennisvannu.nl/site/special/iGEM-2017-studenten-ontwerpen-nieuw-leven/111).  
+
More information and some of the short videos we made can be found on our <a onclick="return change_page('outreach', 1)" href="outreach">Outreach</a> page and on the website of <a target=_BLANK href="https://www.dekennisvannu.nl/site/special/iGEM-2017-studenten-ontwerpen-nieuw-leven/111" class="url_external">“De Kennis van Nu”</a>.  
  
 
<br><br>
 
<br><br>

Revision as of 11:00, 1 November 2017

<!DOCTYPE html>

Cas9 & Cpf1 secretion
and activity
Comparison of endonuclease activity for Cas9 and Cpf1 that has been produced in, and excreted by, HEK293 cells.
MESA two-component system replication
Details on the MESA two-component system, explanation of its relation to our design and the results of its reproduction.
OUTCASST system production
Detailed explanation of the OUTCASST mechanism, experimental progress and technical prospects.
Modeling and
mathematics
Ordinary differential equations, cellular automaton and an object based model for optimal linker-length estimation.
InterLab study participation
Results and details of our measurements for the iGEM 2017 InterLab Study.
Stakeholders & opinions
Interviews and dialogues with stakeholders, potential users, third parties and experts relating to pathogen detection or DNA-based diagnostics.
Risks & safety-issues
Implications and design considerations relating to safety in the usage and implementation of OUTCASST as a diagnostics tool.
Design & integration
OUTCASST toolkit and product design with factors such as bio-safety and user-friendliness taken into account.
Outreach
Videos we made for the dutch public, together with 'de Kennis van Nu'.
Meet our team
About us, our interests and roles in the team and our supervisors.
Sponsors
A listing of our sponsors, how they assisted us and our gratitude for their assistance.
Collaborations
Read about our exchanges with other iGEM teams and government agencies.
Achievements
A short description of all that we have achieved during our participation in the iGEM.
Attributions
A thank-you for everyone that assited us, both in and outside the lab.